Results 121 to 130 of about 40,861 (209)
Population Pharmacokinetics and Exposure-Response Analyses for Venetoclax in Combination with R-CHOP in Relapsed/Refractory and Previously Untreated Patients with Diffuse Large B Cell Lymphoma. [PDF]
Adv Ther, 2022 Samineni D, Huang W, Gibiansky L, Ding H, Zhang R, Li C, Sinha A, Rajwanshi R, Humphrey K, Bazeos A, Salem AH, Miles D. +11 moreeuropepmc +1 more sourceRegional brain morphology and current antidepressant use: findings from 32 international cohorts from the ENIGMA major depressive disorder working group. [PDF]
Mol PsychiatrySerrarens C, Toenders YJ, Pozzi E, Aleman A, Alexander N, Başgöze Z, Belov V, Berger K, Brosch K, Bülow R, Busatto GF, Capitão LP, Connolly CG, Couvy-Duchesne B, Cullen KR, Dannlowski U, Davey CG, de Zubicaray GI, Dima D, Dohm K, Enneking V, Erwin-Grabner T, Evermann U, Fu CHY, Fuentes-Claramonte P, Godlewska BR, Gonul AS, Gotlib IH, Goya-Maldonado R, Grabe HJ, Groenewold NA, Grotegerd D, Gruber O, Hahn T, Hall G, Harrison BJ, Heindel W, Hermesdorf M, Ho TC, Ichikawa N, Itai E, Jahanshad N, Jamalabadi H, Jamieson AJ, Jansen A, Kircher T, Klimes-Dougan B, Krämer B, Krug A, Lancaster TM, Leehr EJ, Li M, Linden DEJ, MacMaster F, McMahon KL, Medland SE, Mehler DMA, Meinert S, Mwangi B, Nenadić I, Okada G, Okamoto Y, Opel N, Pfarr JK, Pomarol-Clotet E, Portella MJ, Redlich R, Reneman L, Repple J, Ringwald K, Rodriguez-Cano E, Rosa PGP, Sacchet MD, Sämann PG, Salvador R, Schrantee A, Shinzato H, Sim K, Simulionyte E, Soares JC, Stein DJ, Stein F, Straube B, Strike LT, Thomas-Odenthal F, Thomopoulos SI, Thompson PM, van Tol MJ, Usemann P, Uyar A, van der Wee N, van der Werff S, Vives-Gilabert Y, Völzke H, Walter M, Whittle S, Wittfeld K, Wroblewski A, Wu MJ, Yang TT, Zunta-Soares GB, Veltman DJ, Schmaal L, van Velzen LS. +103 moreeuropepmc +1 more sourceAutomated Lugano Metabolic Response Assessment in 18F-Fluorodeoxyglucose-Avid Non-Hodgkin Lymphoma With Deep Learning on 18F-Fluorodeoxyglucose-Positron Emission Tomography. [PDF]
J Clin OncolJemaa S, Ounadjela S, Wang X, El-Galaly TC, Kostakoglu L, Knapp A, Ku G, Musick L, Sahin D, Wei MC, Yin S, Bengtsson T, De Crespigny A, Carano RAD. +13 moreeuropepmc +1 more sourceSingle-nucleotide Fcγ receptor polymorphisms do not impact obinutuzumab/rituximab outcome in patients with lymphoma. [PDF]
Blood Adv, 2021 Strefford JC, Nowicka M, Hargreaves CE, Burton C, Davies A, Ganderton R, Hiddemann W, Iriyama C, Klapper W, Latham KV, Martelli M, Mir F, Parker H, Potter KN, Rose-Zerilli MJJ, Sehn LH, Trněný M, Vitolo U, Bolen CR, Klein C, Knapp A, Oestergaard MZ, Cragg MS. +22 moreeuropepmc +1 more sourceGlobal Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. [PDF]
N Engl J Med, 2023 Global Cardiovascular Risk Consortium, Magnussen C, Ojeda FM, Leong DP, Alegre-Diaz J, Amouyel P, Aviles-Santa L, De Bacquer D, Ballantyne CM, Bernabé-Ortiz A, Bobak M, Brenner H, Carrillo-Larco RM, de Lemos J, Dobson A, Dörr M, Donfrancesco C, Drygas W, Dullaart RP, Engström G, Ferrario MM, Ferrières J, de Gaetano G, Goldbourt U, Gonzalez C, Grassi G, Hodge AM, Hveem K, Iacoviello L, Ikram MK, Irazola V, Jobe M, Jousilahti P, Kaleebu P, Kavousi M, Kee F, Khalili D, Koenig W, Kontsevaya A, Kuulasmaa K, Lackner KJ, Leistner DM, Lind L, Linneberg A, Lorenz T, Lyngbakken MN, Malekzadeh R, Malyutina S, Mathiesen EB, Melander O, Metspalu A, Miranda JJ, Moitry M, Mugisha J, Nalini M, Nambi V, Ninomiya T, Oppermann K, d'Orsi E, Pająk A, Palmieri L, Panagiotakos D, Perianayagam A, Peters A, Poustchi H, Prentice AM, Prescott E, Risérus U, Salomaa V, Sans S, Sakata S, Schöttker B, Schutte AE, Sepanlou SG, Sharma SK, Shaw JE, Simons LA, Söderberg S, Tamosiunas A, Thorand B, Tunstall-Pedoe H, Twerenbold R, Vanuzzo D, Veronesi G, Waibel J, Wannamethee SG, Watanabe M, Wild PS, Yao Y, Zeng Y, Ziegler A, Blankenberg S. +91 moreeuropepmc +1 more source
